Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture

Acute Epstein-Barr virus (EBV) infection in immunosuppressed transplant patients can give rise to a malignant B-cell proliferation known as post-transplant lymphoproliferative disease (PTLD). The EBV major virion surface glycoprotein (gp)350 is a principal target of naturally occurring neutralizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanner, Jerome E., Hu, Jing, Alfieri, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923367/
https://www.ncbi.nlm.nih.gov/pubmed/29642526
http://dx.doi.org/10.3390/cancers10040112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923367/
https://www.ncbi.nlm.nih.gov/pubmed/29642526
http://dx.doi.org/10.3390/cancers10040112

Ejemplares similares